4//SEC Filing
Rahmer Peter 4
Accession 0000950170-24-088813
CIK 0001812364other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 6:43 PM ET
Size
11.1 KB
Accession
0000950170-24-088813
Insider Transaction Report
Form 4
Rahmer Peter
See remarks
Transactions
- Sale
Common Stock
2024-07-30$8.28/sh−15,128$125,260→ 405,637 total - Sale
Common Stock
2024-07-29$8.51/sh−12,164$103,516→ 420,765 total - Sale
Common Stock
2024-07-29$8.85/sh−1,359$12,027→ 432,929 total - Sale
Common Stock
2024-07-31$8.19/sh−13,708$112,269→ 391,929 total
Footnotes (6)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units ("RSUs") on July 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 377,937 shares underlying RSUs.
- [F3]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2024.
- [F4]This transaction was executed in multiple trades at prices ranging from $8.22 to $8.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F5]This transaction was executed in multiple trades at prices ranging from $8.09 to $8.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F6]This transaction was executed in multiple trades at prices ranging from $7.96 to $8.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Relay Therapeutics, Inc.
CIK 0001812364
Entity typeother
Related Parties
1- filerCIK 0001959229
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 6:43 PM ET
- Size
- 11.1 KB